KERATIN YK93-5, PREPARATION METHOD, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF

• Main Authors: YU, Shishan, HAO, Mengyao, LI, Yong, QU, Jing, WANG, Mingjin, FU, Jiang, LI, Mi, JIN, Jing, WANG, Xiaojing, MA, Shuanggang, LIU, Yunbao, LI, Shuying, SHI, Guoru, CHEN, Xiaoguang, JIANG, Huimin
• Format: Patent
• Language: Chinese; English; French
• Published: 11.04.2024
• Subjects: BEER; BIOCHEMISTRY; CHEMISTRY; COMPOSITIONS THEREOF; CULTURE MEDIA; ENZYMOLOGY; FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE; HUMAN NECESSITIES; HYGIENE; MEDICAL OR VETERINARY SCIENCE; METALLURGY; MICROBIOLOGY; MICROORGANISMS OR ENZYMES; MUTATION OR GENETIC ENGINEERING; ORGANIC CHEMISTRY; PEPTIDES; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS; SPIRITS; VINEGAR; WINE

The present invention relates to the field of biological pharmacy, provides keratin YK93-5, a nucleic acid molecule encoding same, an expression vector containing the nucleic acid molecule, a host cell containing the expression vector or a genome integrated with the nucleic acid molecule, a preparation method for the keratin YK93-5, and a pharmaceutical composition of the keratin YK93-5, and further provides a use of the products such as the keratin YK93-5 in the preparation of drugs for treating lung cancer, lymphoma, breast cancer, melanoma, uterine fibroids, prostatic hyperplasia, etc. La présente invention relève du domaine de la pharmacie biologique, et concerne la kératine YK93-5, une molécule d'acide nucléique codant pour celle-ci, un vecteur d'expression contenant la molécule d'acide nucléique, une cellule hôte contenant le vecteur d'expression ou un génome intégré à la molécule d'acide nucléique, un procédé de préparation de la kératine YK93-5, et une composition pharmaceutique de la kératine YK93-5,